These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26797414)

  • 1. Galectin-9: An anticancer molecule for gallbladder carcinoma.
    Tadokoro T; Morishita A; Fujihara S; Iwama H; Niki T; Fujita K; Akashi E; Mimura S; Oura K; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Himoto T; Hirashima M; Masaki T
    Int J Oncol; 2016 Mar; 48(3):1165-74. PubMed ID: 26797414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.
    Kobayashi K; Morishita A; Iwama H; Fujita K; Okura R; Fujihara S; Yamashita T; Fujimori T; Kato K; Kamada H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2015 Oct; 34(4):1761-70. PubMed ID: 26260906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
    Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T
    Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway.
    Jia J; Li S; Gong W; Ding J; Fang C; Quan Z
    Oncol Rep; 2011 Jan; 25(1):195-201. PubMed ID: 21109977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.
    Akashi E; Fujihara S; Morishita A; Tadokoro T; Chiyo T; Fujikawa K; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
    Oncol Rep; 2017 Jul; 38(1):506-514. PubMed ID: 28586026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
    Qiu Y; Li X; Yi B; Zheng J; Peng Z; Zhang Z; Wu M; Shen F; Su C
    Oncotarget; 2015 Aug; 6(22):19148-62. PubMed ID: 25895131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.
    Fujita K; Iwama H; Sakamoto T; Okura R; Kobayashi K; Takano J; Katsura A; Tatsuta M; Maeda E; Mimura S; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Yamana Y; Himoto T; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
    Int J Oncol; 2015; 46(6):2419-30. PubMed ID: 25823465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
    Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
    Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
    Mohri D; Ijichi H; Miyabayashi K; Takahashi R; Kudo Y; Sasaki T; Asaoka Y; Tanaka Y; Ikenoue T; Tateishi K; Tada M; Isayama H; Koike K
    J Gastroenterol; 2016 Jul; 51(7):711-21. PubMed ID: 26614007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
    Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
    Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor Effect of Galectin-9 on Cell Proliferation and Tumor Growth of Human Duodenal Adenocarcinoma Cells.
    Kono T; Fujihara S; Oura K; Iwama H; Fujita K; Fujita N; Takuma K; Ono M; Namima D; Yamana H; Chiyo T; Kobayashi K; Kamada H; Kobara H; Ono M; Niki T; Hirashima M; Masaki T
    Anticancer Res; 2023 Aug; 43(8):3769-3777. PubMed ID: 37500141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    Takada N; Sugano H; Shirai Y; Saito N; Hamura R; Taniai T; Uwagawa T; Yanaga K; Ikegami T; Ohashi T; Eto K
    PLoS One; 2021; 16(9):e0257019. PubMed ID: 34473771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study.
    Tadokoro T; Fujihara S; Chiyo T; Oura K; Samukawa E; Yamana Y; Fujita K; Mimura S; Sakamoto T; Nomura T; Tani J; Yoneyama H; Morishita A; Himoto T; Iwama H; Niki T; Hirashima M; Masaki T
    Int J Oncol; 2017 Aug; 51(2):607-614. PubMed ID: 28656219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
    Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
    Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.